Virtu KCG Holdings’s Enlivex Therapeutics ENLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q2
$8K Sell
287
-387
-57% -$10.8K ﹤0.01% 2778
2017
Q1
$20K Buy
674
+298
+79% +$8.84K ﹤0.01% 2955
2016
Q4
$16K Buy
+376
New +$16K ﹤0.01% 3234
2016
Q2
Sell
-544
Closed -$54K 3018
2016
Q1
$54K Buy
544
+283
+108% +$28.1K ﹤0.01% 2439
2015
Q4
$40K Buy
+261
New +$40K ﹤0.01% 2657